GINESAN MEDICAL SLP
Company details
- Active NIF/CIF: B92911155
-
Telephone: Not available
-
Date of last BORME entry: 07/09/2011
-
Sector: Human Health and Social Work Activities
-
Address: C/ LINDAVISTA 42 2 B - URB GUADALCANTARA SAN PED (MARBELLA)
-
Website: Not available
-
Featured products:
More information on GINESAN MEDICAL SLP
-
07/09/2011 | BORME act no.: 449216 | Register: MÁLAGADepósito de cuentas anuales (Agosto de 2011) -
13/09/2010 | BORME act no.: 532730 | Register: MÁLAGADepósito de cuentas anuales (Agosto de 2010)
-
23/09/2009 | BORME act no.: 461483 | Register: MÁLAGADepósito de cuentas anuales (Septiembre de 2009)
-
06/05/2008 | BORME act no.: 228665 | Register: MÁLAGAConstitución
-
06/05/2008 | BORME act no.: 228665 | Register: MÁLAGADeclaración de unipersonalidad
-
06/05/2008 | BORME act no.: 228665 | Register: MÁLAGANombramientos
Other information
The CIF assigned to GINESAN MEDICAL SLP is B92911155, and its current commercial status is active. The company is engaged in economic activities within the CNAE 8610 - Hospital activities. As for its SIC classification, it is 8069 - Hospitales especializados.
The company GINESAN MEDICAL SLP has a team of Between 10 and 49 employees and reports annual revenues of less than 2 million euros. Registered in the Mercantile Registry of Málaga, it has a total of 2 registered positions. Its most recent announcement in the Borme was published on 07/09/2011, and the last deposit of its annual accounts corresponds to the year -.
To find out more contact details of GINESAN MEDICAL SLP, such as telephone number, address, or website, you can consult the Company Data module.
If you want to obtain more information about GINESAN MEDICAL SLP, you can review one of the available financial reports, the company's Annual Accounts, or check for any default incidents in the RAI delinquency file.
The financial, commercial, and legal information of GINESAN MEDICAL SLP comes from official sources and is constantly updated.
Do you want to know more about GINESAN MEDICAL SLP??
Find out more about this company by consulting these reports:
